Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Hydreight Technologies Inc ( (TSE:NURS) ) is now available.
Hydreight Technologies has surpassed 1.3 million product orders placed ahead of year-end, beating its full-year 2025 operational target and underscoring strong platform adoption and partner demand. The company has also grown its ecosystem to approximately 2,500 licenses, far above its 2025 goal of 1,000, although most are still in onboarding or early activation and not yet contributing significantly to order volume, positioning Hydreight for increased utilization and scale as these licenses mature and as it advances its VSDHOne 2.0 platform and broader digital health infrastructure strategy into 2026.
The most recent analyst rating on (TSE:NURS) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Hydreight Technologies Inc stock, see the TSE:NURS Stock Forecast page.
More about Hydreight Technologies Inc
Hydreight Technologies Inc. is a U.S.-focused digital health company that provides compliant digital health infrastructure and on-demand healthcare services, enabling healthcare brands, clinics, and enterprises to operate across all 50 states through a unified technology, clinical, pharmacy, and regulatory framework. Its platform includes the VSDHOne enterprise vertical, which supports licensed partners in delivering healthcare services at scale while meeting regulatory and operational requirements.
Average Trading Volume: 142,167
Technical Sentiment Signal: Buy
Current Market Cap: C$124.6M
See more data about NURS stock on TipRanks’ Stock Analysis page.